CONTINUE TO SITE
OR WAIT 15 SECS
China-based Viva Biotech recently held the AIDD platform launch event "Enchantment of Drug Discovery," unveili
The Abu Dhabi Public Health Centre (ADPHC) has signed a two-year Memorandum of Understanding (MoU) with Gilead
American firm Curaleaf International, part of Curaleaf Holdings, Inc., has announced the launch of Curaleaf br
Administered through the National Health and Medical Research Council’s (NHMRC) Clinical Trials and
Rznomics Inc., a South Korea-based biopharmaceutical startup specialising in RNA-based therapeutics, has
Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driv
US-based Illumina, a global leader in DNA sequencing and array-based technologies, and the Okinawa Institute o
The Division of Oral and Maxillofacial Surgery (OMFS) of the Faculty of Dentistry at the University of Hong Ko
Sanyou Biopharmaceuticals Co. and TransRecoBio Biotechnology Co. have signed a strategic cooperation agreement
US-based AGC Biologics, a global Contract Development and Manufacturing Organisation (CDMO), has announced a m
APAC Vaccine Powerhouses Flex Capacity & Quality Muscle
Asia is the epicentre of global vaccine manufacturing, with India and China together supplying over a billion doses annually. Now, emerging players like South Korea, Singapore, and Australia are stepping up, investing in next-gen platforms and expanding capacity to meet global demand. Let’s map the manufacturing footprint of Asia’s leading vaccine manufacturers, tracking their current capacity, expansion plans, and the strategic shifts that are transforming the region into a global vaccine production hub.
ISPOR 2025
ISPOR
info@ispor.org https://www.ispor.org/conferences-education/event/2025/05/13/default-calendar/ispor-2025Montreal
Cell Gene Meeting on the Med 2025
"Alliance for Regenerative Medicine"
sbryant@alliancerm.org https://alliancerm.org/arm-event/meetingonthemed/Rome
